Testosterone and Cardiovascular Risk in Men: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials-Reference-Cited by-同舟云学术

Testosterone and Cardiovascular Risk in Men: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials

Published:2007-01 Issue:1 Volume:82 Page:29-39
ISSN:0025-6196
Container-title:Mayo Clinic Proceedings
language:en
Short-container-title:Mayo Clinic Proceedings

Author:

Haddad Rudy M.,Kennedy Cassie C.,Caples Sean M.,Tracz Michal J.,Boloña Enrique R.,Sideras Kostandinos,Uraga Maria V.,Erwin Patricia J.,Montori Victor M.

Publisher

Elsevier BV

Subject

General Medicine

Reference44 articles.

1. Intramuscular testosterone esters and plasma lipids in hypogonadal men: a meta-analysis;Whitsel;Am J Med,2001

2. Steroid sex hormones for lower limb atherosclerosis. [update of Cochrane Database Syst Rev. 2000;2:CD000188];Price;Cochrane Database Syst Rev,2002

3. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement;Moher;Lancet,1999

4. Testosterone therapy in adult men with androgen deficiency syndromes: an Endocrine Society clinicalpractice guideline;Bhasin;J Clin Endocrinol Metab,2006

5. Estimators of the Mantel-Haenszel variance consistent in both sparse data and large-strata limiting models;Robins;Biometrics,1986

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of male obesity-related secondary hypogonadism: A clinical update;World Journal of Experimental Medicine;2024-06-20

2. Higher testosterone and testosterone/estradiol ratio in men are associated with decreased Pheno-/GrimAge and DNA-methylation based PAI1;GeroScience;2023-06-27

3. Higher testosterone and testosterone/estradiol ratio in men are associated with better epigenetic estimators of mortality risk;2023-02-23

4. The influence of testosterone on the risk of cardiovascular events after percutaneous coronary intervention;Frontiers in Cardiovascular Medicine;2022-12-22

5. Commentary on: Testosterone replacement therapy and cardiovascular disease;International Journal of Impotence Research;2022-10-05